Literature DB >> 25815993

A century of cholesterol and coronaries: from plaques to genes to statins.

Joseph L Goldstein1, Michael S Brown2.   

Abstract

One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815993      PMCID: PMC4525717          DOI: 10.1016/j.cell.2015.01.036

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  92 in total

1.  Lessons from serum cholesterol studies in Japan, Hawaii and Los Angeles.

Authors:  A KEYS; N KIMURA; A KUSUKAWA; B BRONTE-STEWART; N LARSEN; M H KEYS
Journal:  Ann Intern Med       Date:  1958-01       Impact factor: 25.391

2.  Oxidized low-density lipoprotein and atherosclerosis.

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

3.  Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs.

Authors:  R B Rawson; N G Zelenski; D Nijhawan; J Ye; J Sakai; M T Hasan; T Y Chang; M S Brown; J L Goldstein
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

4.  The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease.

Authors:  John W Gofman; Oliver Delalla; Frank Glazier; Norman K Freeman; Frank T Lindgren; Alex V Nichols; Beverly Strisower; Arthur R Tamplin
Journal:  J Clin Lipidol       Date:  2007-05       Impact factor: 4.766

5.  Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.

Authors:  Thomas A Lagace; David E Curtis; Rita Garuti; Markey C McNutt; Sahng Wook Park; Heidi B Prather; Norma N Anderson; Y K Ho; Robert E Hammer; Jay D Horton
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

6.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

7.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

Authors:  X Wang; R Sato; M S Brown; X Hua; J L Goldstein
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

8.  Comparison of the serum low density lipoprotein and of its apoprotein in the pig, rhesus monkey and baboon with that in man.

Authors:  M J Chapman; S Goldstein
Journal:  Atherosclerosis       Date:  1976 Nov-Dec       Impact factor: 5.162

9.  Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins.

Authors:  Li-Ping Sun; Joachim Seemann; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

10.  Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment.

Authors:  Ebele Usifo; Sarah E A Leigh; Ros A Whittall; Nicholas Lench; Alison Taylor; Corin Yeats; Christine A Orengo; Andrew C R Martin; Jacopo Celli; Steve E Humphries
Journal:  Ann Hum Genet       Date:  2012-09       Impact factor: 1.670

View more
  289 in total

Review 1.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Protective alleles and modifier variants in human health and disease.

Authors:  Andrew R Harper; Shalini Nayee; Eric J Topol
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

Review 3.  Genetically engineered livestock for biomedical models.

Authors:  Christopher S Rogers
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

4.  How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research.

Authors:  Peter Libby; Karin E Bornfeldt
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 5.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

Review 6.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish.

Authors:  Chao Liu; Young Sook Kim; Jungsu Kim; Jennifer Pattison; Andrés Kamaid; Yury I Miller
Journal:  J Lipid Res       Date:  2017-11-29       Impact factor: 5.922

8.  The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.

Authors:  Q Feng; W Q Wei; C P Chung; R T Levinson; L Bastarache; J C Denny; C M Stein
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

9.  Membrane cholesterol as regulator of human rhomboid protease RHBDL4.

Authors:  Sandra Paschkowsky; Sherilyn Junelle Recinto; Jason C Young; Ana-Nicoleta Bondar; Lisa Marie Munter
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

Review 10.  The interplay between cell signalling and the mevalonate pathway in cancer.

Authors:  Peter J Mullen; Rosemary Yu; Joseph Longo; Michael C Archer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.